Parschauer Karah Herdman 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
Parschauer Karah Herdman
EVP and Chief Legal Officer
Transactions
- Sale
Common Stock
2024-06-12$45.00/sh−9,806$441,270→ 57,981 total
Footnotes (2)
- [F1]Includes 447 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2024.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.